These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

71 related articles for article (PubMed ID: 4921093)

  • 1. The virulence of some strains of BCG for golden hamsters. Further studies.
    Bunch-Christensen K; Ladefoged A; Guld J
    Bull World Health Organ; 1970; 43(1):65-70. PubMed ID: 4921093
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The virulence of some strains of BCG for golden hamsters.
    Bunch-Christensen K; Ladefoged A; Guld J
    Bull World Health Organ; 1968; 39(5):821-8. PubMed ID: 4893582
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of freeze-dried vaccines prepared from four different strains of BCG.
    Landi S; Barbara C; Przykuta K; Held HR
    Dev Biol Stand; 1977 Apr 13-15; 38():19-28. PubMed ID: 608506
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Preparation of a working seed lot of BCG and quality control by PCR genotyping.
    Trovero A; Argüelles C; Cataldi A
    Rev Argent Microbiol; 2010; 42(1):4-10. PubMed ID: 20461286
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The efficacy of live tuberculosis vaccines after presensitization with Mycobacterium avium.
    de Lisle GW; Wards BJ; Buddle BM; Collins DM
    Tuberculosis (Edinb); 2005; 85(1-2):73-9. PubMed ID: 15687030
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Variability of the BCG Moreau substrain. I. Comparison of morphology and residual virulence of BCG substrains of various origins].
    Janaszek W
    Med Dosw Mikrobiol; 1983; 35(2):85-95. PubMed ID: 6369042
    [No Abstract]   [Full Text] [Related]  

  • 7. [Residual virulence of lyophilized commercial BCG-Brazil vaccine, and of the one cultured in Dubos media for mice].
    Fonseca Lde S; Gontijo Filho PP
    An Microbiol (Rio J); 1979; 24():182-9. PubMed ID: 400665
    [No Abstract]   [Full Text] [Related]  

  • 8. THE VIRULENCE OF VARIOUS STRAINS OF BCG DETERMINED ON THE GOLDEN HAMSTER.
    JESPERSEN A; BENTZON MW
    Acta Tuberc Pneumol Scand; 1964; 44():222-49. PubMed ID: 14166145
    [No Abstract]   [Full Text] [Related]  

  • 9. Differential productions of lipid virulence factors among BCG vaccine strains and implications on BCG safety.
    Chen JM; Islam ST; Ren H; Liu J
    Vaccine; 2007 Nov; 25(48):8114-22. PubMed ID: 17954004
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Modifications induced in golden hamster by intracerebral inoculation of Mycobacterium bovis-BCG.
    Stavri D; Petrovici M; Ciufecu E; Costache G
    Arch Roum Pathol Exp Microbiol; 1984; 43(1):71-5. PubMed ID: 6397173
    [No Abstract]   [Full Text] [Related]  

  • 11. The residual virulence of the Rumanian strain of B.C.G.
    Drăghici D; Andronescu F; Olinescu E; Georgescu L; Bordasiu R
    Arch Roum Pathol Exp Microbiol; 1974; 33(3-4):261-6. PubMed ID: 4619553
    [No Abstract]   [Full Text] [Related]  

  • 12. Comparative studies of 5 BCG substranins. I. Residual virulence of the French, Soviet, Swedish, Japanese and Rumanian substrains.
    Gheorghiu M; Paraschiveso M; Petrovici-Venson E
    Arch Roum Pathol Exp Microbiol; 1969; 28(2):531-9. PubMed ID: 4923821
    [No Abstract]   [Full Text] [Related]  

  • 13. The effect of passaging in liquid media and storage on Mycobacterium bovis--BCG growth capacity and infectivity.
    Nascimento IP; Leite LC
    FEMS Microbiol Lett; 2005 Feb; 243(1):81-6. PubMed ID: 15668004
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Report of an international collaborative study to establish the suitability of using modified ATP assay for viable count of BCG vaccine.
    Ho MM; Markey K; Rigsby P; Jensen SE; Gairola S; Seki M; Castello-Branco LR; López-Vidal Y; Knezevic I; Corbel MJ
    Vaccine; 2008 Aug; 26(36):4754-7. PubMed ID: 18586063
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The genetic regulation of host response to inoculation with Mycobacterium bovis (BCG) and Mycobacterium tuberculosis H37RV].
    Nikonenko BV; Mezhlumova MB; Moroz AM
    Biull Eksp Biol Med; 1990 Nov; 110(11):526-8. PubMed ID: 2128037
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Multiplication of bacteria of BCG substrains in the bodies of white mice and golden hamsters].
    Rozenberg AM
    Zh Mikrobiol Epidemiol Immunobiol; 1969 Mar; 46(3):97-103. PubMed ID: 4891315
    [No Abstract]   [Full Text] [Related]  

  • 17. Changes in BCG strains.
    Osborn TW
    Tubercle; 1983 Mar; 64(1):1-13. PubMed ID: 6342243
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparative studies with Danish and Prague BCG strains inoculated into the cornea of the rabbits in repeated experiments.
    Struplová V; Obrucnik M
    J Hyg Epidemiol Microbiol Immunol; 1975; 19(4):490-1. PubMed ID: 1107420
    [No Abstract]   [Full Text] [Related]  

  • 19. [Influence of the inoculation route on residual virulence of different substrains of BCG for albino mice].
    Palhano Junior L; Gontijo Filho PP
    Rev Inst Med Trop Sao Paulo; 1980; 22(1):15-9. PubMed ID: 7001603
    [No Abstract]   [Full Text] [Related]  

  • 20. Nicotinic acid production of BCG substrains in relationship to their residual virulence and immunogenic efficacy.
    Zureck A
    J Hyg Epidemiol Microbiol Immunol; 1975; 19(4):436-43. PubMed ID: 812905
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.